KNSA
KINIKSA PHARMA (KNSA)
NASDAQ
$61.35+$0.41 (+0.66%)
Price as of Jul 14, 2026 5:38 AM EDT
  • $2.6B
    Market Cap
  • 111.60%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry

Earnings Score

Score: 72
Valuation
KNSA
vs History
vs S&P 500
Profitability
1
Growth
1
Low Earnings Volatility
0

Momentum Score

Score: 86
Valuation
KNSA
vs History
vs S&P 500
3-Month Momentum
4.76%
12-Month Momentum
75.40%
3-Month Risk Adjusted Momentum
17.13%
12-Month Risk Adjusted Momentum
180.41%

True Yield

N/A
Valuation
KNSA
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
N/A
Net Debt Paydown Yield
N/A

Financial Health Score

Score: 83
Valuation
KNSA
vs History
vs S&P 500
Ohlson's O-Score
10